Method Article

Visualization of Protein-protein Interaction in Nuclear and Cytoplasmic Fractions by Co-immunoprecipitation and In Situ Proximity Ligation Assay

DOI:

10.3791/55218

January 16th, 2017

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Protein-protein interactions can occur in both the nucleus and the cytoplasm of a cell. To investigate these interactions, traditional co-immunoprecipitation and modern proximity ligation assay are applied. In this study, we compare these two methods to visualize the distribution of NF90-RBM3 interactions in the nucleus and the cytoplasm.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Protein-protein interactions are involved in thousands of cellular processes and occur in distinct spatial context. Traditionally, co-immunoprecipitation is a popular technique to detect protein-protein interactions. Subsequent Western blot analysis is the most common method to visualize co-immunoprecipitated proteins. Recently, the proximity ligation assay has become a powerful tool to visualize protein-protein interactions in situ and provides the possibility to quantify protein-protein interactions by this method. Similar to conventional immunocytochemistry, the proximity ligation assay technique is also based on the accessibility of primary antibodies to the antigens, but in contrast, proximity ligation assay detects protein-protein interactions with a unique technique involving rolling-circle PCR, while conventional immunocytochemistry only shows co-localization of proteins.

Nuclear factor 90 (NF90) and RNA-binding motif protein 3 (RBM3) have been previously demonstrated as interacting partners. They are predominantly localized in the nucleus, but also migrate into the cytoplasm and regulate signaling pathways in the cytoplasmic compartment. Here, we compared NF90-RBM3 interaction in both the nucleus and the cytoplasm by co-immunoprecipitation and proximity ligation assay. In addition, we discussed the advantages and limitations of these two techniques in visualizing protein-protein interactions in respect to spatial distribution and the properties of protein-protein interactions.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Nuclear factor 90 (NF90) is a multi-isoform protein with numerous functions including the response to viral infection, regulation of interleukin-2 post-transcription and regulation of miRNA biogenesis 1-3. RBM3 is an RNA-binding protein, involved in translation and miRNA biogenesis and can be induced by various stressors including hypothermia and hypoxia 4-6. Recently, we found NF90 and RBM3 in a protein complex 7. The interaction of NF90 and RBM3 is essential to modulate protein kinase RNA-like endoplasmic reticulum kinase (PERK) activity in unfolded protein response 7. Both NF90 and RBM3 are located predominantly in the nucleus but a small proportion of NF90 and RBM3 shuttle into the cytoplasm and bind there to each other for specific functions, e.g. to regulate PERK activity. Therefore, it is important to visualize the distribution of NF90-RBM3 interactions in the subcellular compartment, which may indicate their various roles in respective compartment.

Decades ago, yeast two hybrid (Y2H) was developed to detect the interaction between two proteins 8. However, due to artificial construction of fused proteins, false positive results have restricted the application of this method. For a long time, co-immunoprecipitation was the main technique to analyze protein-protein interactions, especially in endogeneous conditions 9. To analyze the co-immunoprecipitated protein complex, Western blot is the most convenient technique, while mass spectrometry is used when super sensitivity and accuracy are desired. In recent years, proximity ligation assay has been developed as a novel method to detect protein-protein interactions in both cells and tissues in situ 10,11.

Here, we compared the most popular co-immunoprecipitation method and relatively novel proximity ligation assay method in capturing NF90-RBM3 interaction in subcellular fractions. We also discussed the advantages and limitations of both techniques.

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

1. Co-immunoprecipitation

  1. Seed HEK293 cells at 2 x 105 cells per well in one 6-well plate in 2 ml Dulbecco's Modified Eagle's Medium (DMEM) supplement with 10% fetal bovine serum (FBS) and 100 U/mL Penicillin-Streptomycin (Pen-Strep).
  2. Grow cells for 48 hr at 37 °C with 5% CO2.
  3. Wash cells with cold phosphate-buffered saline (PBS) three times. Harvest cells by centrifugation at 500 x g for 5 min at 4 °C.
  4. Prepare nuclear and cytoplasmic fractions using commercial nuclear and cytoplasmic extraction reagents. Follow manufacturer's instruction with some modifications.
    1. Use 3 x 106 cells for one co-immunoprecipitation experiment (approximately with 90% confluency from 3 wells of one 6-well plate). Add 300 µl cold cytoplasmic extraction solution (CER I) and vortex for 15 sec at the highest speed.
    2. Incubate for 30 min on ice. During incubation, vortex for 5 s every 10 min.
    3. Add 16.5 µl cold cytoplasmic extraction solution II (CER II), vortex for 5 sec and incubate for 5 min on ice.
    4. Vortex for 5 sec and centrifuge at 16,000 x g for 5 min at 4 °C.
    5. Transfer supernatant (cytoplasmic extract) into a new pre-chilled tube, and keep on ice until used.
    6. Wash insoluble pellets (containing nuclei) three times with 1 ml cold PBS each time by pipetting up and down five times. Remove PBS after wash.
    7. Add 150 µl cold nuclear extraction solution (NER), vortex for 15 sec and incubate 1 hr on ice. During incubation, vortex for 15 sec and pipette 10 times with a 200 µl tip every 10 min.
    8. Vortex for 15 s and centrifuge at 16,000 x g for 10 min at 4 °C.
    9. Transfer supernatant (nuclear extract) into a new pre-chilled tube, keep on ice until use.
  5. Take out 10% of the volume of nuclear and cytoplasmic extracts each as inputs.
  6. Add cold PBS to the remaining extracts to a final volume of 1 ml. Keep on ice until use.
    NOTE: Pre-clearing is not essential when using Protein G-conjugated magnetic beads. However, if the background is high, perform pre-clearing by incubating 40 µl Protein G-conjugated magnetic beads (50% slurry) and 1 ml diluted lysate from this step at 4 °C for 30 min on a rotator. Separate supernatant (pre-cleared lysate) from beads with magnetic rack. Discard the beads.
  7. To couple primary antibody with Protein G-conjugated magnetic beads, incubate 40 µl Protein G-conjugated magnetic beads (50% slurry) with 4 µg rabbit polyclonal anti-RBM3 antibody or rabbit IgG (negative control) in 200 µl PBS plus Tween 20 buffer (PBST, 0.02% Tween 20) at room temperature (RT) for 40 min on a rotator.
  8. Separate antibody-coupled beads and supernatant with a magnetic rack, and discard the supernatant. Wash the beads once with 200 µl PBST (0.02%).
  9. Add 1 ml diluted lysates (or if necessary, pre-cleared lysates) to the beads, and incubate on a rotator at 4 °C overnight.
  10. On the next day, separate the beads and supernatant by a magnetic rack, and discard the supernatant. Wash 3 x 10 min with 0.5 ml PBST (0.02%) for each tube at 4 °C on a rotator with a fixed speed of 20 rpm.
  11. Elute proteins from the beads by adding 40 µl sample buffer (1x commercial sample buffer and 50 mM 1,4-dithiothreitol (DTT)). Heat at 70 °C for 10 min. Spin down and transfer liquids to a new 1.5 ml tube.
  12. Dilute input lysates in sample buffer (final concentration: 1x commercial sample buffer and 50 mM DTT) and heat at 70 °C for 10 min. Load inputs and immunoprecipitated proteins from the last step to a precast 4-12% bis-Tris gel. The loading volume of each well should not exceed 20 µl. Perform electrophoresis in 1x commercial running buffer on ice for 35 min.
    NOTE: Load nuclear and cytoplasmic extracts in a ratio of 1:2 (V/V), which reflects the same initial amount of cells.
  13. Transfer proteins to PVDF membrane in 1x commercial transfer buffer at 30 V for 2 hr at 4 °C.
  14. Block membrane with 5% skimmed milk in PBST (0.1% Tween 20) at RT for 40 min on a shaker.
  15. Incubate membrane with primary antibodies (both diluted in 1:1,000) in PBST (0.1%) at 4 °C overnight.
  16. Wash 3 x 10 min with PBST (0.1%) at RT on a shaker.
  17. Incubate membrane with horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit secondary antibodies (both diluted in 1:5,000) in PBST (0.1%) at RT for 1 hr.
  18. Wash 3 x 10 min with PBST (0.1%) at RT on a shaker.
  19. Use 0.2 ml enhanced chemiluminescence (ECL) substrate mixture per cm2 membrane, incubate at RT for 5 min. Avoid all light from this step onwards except red lights.
  20. Discard liquid and expose to an X-ray film in a film cassette. Develop film using an automatic film processing machine.

2. Immunocytochemistry and Proximity Ligation Assay

  1. Seed HEK293 cells at 1.5 x 104 cells per chamber in one 8-chamber poly-D-lysine coated slide in 0.4 ml DMEM supplemented with 10% FBS and 100 U/ml Pen-Strep.
  2. Grow cells for 48 hr at 37 °C with 5% CO2.
  3. Aspirate medium, and fix cells with 4% paraformaldehyde (PFA) for 10 min at RT.
  4. Aspirate PFA, and wash 3 x 10 min with 0.5 ml PBS per chamber.
  5. Permeabilize and block cells with 0.5% Triton X-100 and 5% normal goat serum (NGS) in PBS at RT for 1 hr.
  6. Incubate with primary antibodies in 0.1% Triton X-100 and 5% NGS in PBS on a shaker at 4 °C overnight. Dilute mouse monoclonal anti-NF90 antibody and rabbit polyclonal anti-RBM3 antibody 1:100 in PBS for double-staining. For negative control, omit independently either of the two primary antibodies, and omit both antibodies in a third control.
    NOTE: Do not use commercial blocking and diluting reagents.
  7. Wash 3 x 10 min with 0.5 ml PBS per chamber.
  8. Subject to immunocytochemistry or proximity ligation assay protocols
    1. Immunocytochemistry
      1. Incubate with 1:500 diluted green fluorescent dye-coupled anti-mouse and red fluorescent dye-coupled anti-rabbit secondary antibodies at RT for 1 hr. Avoid light from this step onwards.
      2. Counterstain nuclei with 4′, 6-diamidin-2-phenylindol (DAPI) diluted 1:5,000 in PBS at RT for 10 min.
      3. Wash 3 x 10 min with 0.5 ml PBS per chamber.
      4. Remove the chambers from the glass slide and dry. Mount with 250 µ, mounting medium per slide.
    2. Proximity ligation assay
      1. Prepare proximity ligation assay probes. Mix and dilute two proximity ligation assay probes (anti-mouse and anti-rabbit secondary antibodies attached with different oligonucleotides which can ligate through the addition of two other oligonucleotides in ligation solution) both 1:5 in 0.1% Triton X-100 and 5% NGS in PBS, with a total volume of 320 µl for one 8-chamber slide (approximately 40 µl per cm2). Incubate at RT for 20 min.
      2. Remove the chambers from the glass slide and add the diluted probes. Incubate in a humidity incubator at 37 °C for 1 hr.
      3. Prepare ligation solution. Mix 8 µl ligase, 64 µl 5 x ligation stock and 248 µl H2O.
      4. Tap off the liquid from the slide, and wash 2 x 5 min in 1x Wash Buffer A (provided with the kit).
      5. Add ligation solution and incubate in a humidity incubator at 37 °C for 30 min.
      6. Prepare amplification solution. Mix 4 µl polymerase, 64 µl 5x amplification stock and 252 µl H2O. Avoid light from this step onwards.
      7. Tap off liquid from the slide, and wash 2 x 2 min in 1x Wash Buffer A.
      8. Add the amplification solution and incubate in a dark humidity incubator at 37 °C for 100 min.
      9. Tap off the liquid from the slide, and wash 2 x 10 min in 1x Wash Buffer B (provided with the kit). Wash for 1 min in 0.01x Wash Buffer B.
      10. Dry the slide and mount with 250 µl of a commercial mounting medium (with DAPI) per slide.
  9. Examine fluorescent signals under a microscope using a 10X eyepiece lens and 20X objective lens. Acquire images by a CCD camera.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Figure 1 demonstrates that NF90 and RBM3 are both nuclear proteins and only a small fraction is present in the cytoplasm. Notably, there are three different bands stained positive for RBM3. The smallest just below 20 kDa reflects the correct size of RBM3 (the predicted molecular weight of RBM3 is 17 kDa). The origin of the two other bands remains to be investigated. Co-immunoprecipitation experiments with RBM3 as the bait protein revealed that NF90-RBM3 interactions are p...

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

There are several benefits as well as shortcomings for both methods. As a relatively novel technique, an obvious advantage of proximity ligation assay is the feasibility to elucidate protein-protein interactions at single-cell level instead of a batch of heterogeneous cells. Images with high magnitude and resolution (e.g. by confocal microscope) provide the possibility for quantification by counting single fluorescent spots. In contrast, the conventional combination of co-immunoprecipitation technique with Weste...

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study was supported by the Swiss National Science Foundation (SNSF, 31003A_163305).

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Dulbecco's Modified Eagle’s Medium (DMEM)SigmaD6429High glucose
4,500 mg/L
Fetal bovine serum (FBS)Gibco, Thermo Fisher Scientific10270106
Penicillin-Streptomycin (PenStrep)BioConcept4-01F00-H
NE-PER Nuclear and Cytoplasmic Extraction ReagentsThermo Fisher Scientific78833
1,4-Dithiothreitol (DTT)Carl Roth6908.3
Dynabeads Protein GNovex, Thermo Fisher Scientific10003D
DRBP76 (NF90/NF110) antibodyBD Transduction Laboratories612154use 1:1,000 for WB and 1:100 for ICC/PLA
RBM3 antibodyProteinTech14363-1-APuse 1:1,000 for WB and 1:100 for ICC/PLA
Lamin A/C antibodyCell Signaling Technology#2032use 1:1,000 for WB 
anti-GAPDH antibodyAbcamab8245use 1:1,000 for WB 
normal rabbit IgGSanta Cruzsc-2027
anti-rabbit IgG, HRP-linked secondary antibodyCell Signaling Technology#7074use 1:5,000 for WB 
anti-mouse HRP secondary antibodyCarl Roth4759.1use 1:5,000 for WB 
Clarity Western ECL Blotting SubstrateBio-Rad#1705060
NuPAGE Novex 4-12% Bis-Tris GelNovex, Thermo Fisher ScientificNP0321BOX
NuPAGE LDS Sample Buffer (4x)Novex, Thermo Fisher ScientificNP0007
NuPAGE MES SDS Running Buffer (20x)Novex, Thermo Fisher ScientificNP0002
NuPAGE Transfer Buffer (20x)Novex, Thermo Fisher ScientificNP00061
Amersham Hypond P 0.2 PVDF membraneGE Healthcare Life Sciences10600021
Poly-D-Lysine 8 Well Culture SlideCorning BioCoat354632
Paraformaldehyde (PFA)SigmaP6148
Normal goat serum (NGS)Gibco, Thermo Fisher ScientificPCN5000
Goat anti-mouse IgG (H+L Antibody), Alexa Fluor 488 conjugateThermo Fisher ScientificA-11001
Goat anti-rabbit IgG (H+L Antibody), Alexa Fluor 568 conjugateThermo Fisher ScientificA-11011
4′, 6-Diamidin-2-phenylindol (DAPI)SigmaD9542
Duolink PLA probe Anti-mouse PLUSSigmaDUO92001
Duolink PLA  probe Anti-rabbit MINUSSigmaDUO92005
Duolink Detection Reagents RedSigmaDUO92008
Duolink Wash Buffers FluorescenceSigmaDUO82049
Duolink Mounting Medium with DAPISigmaDUO82040
Mowiol 4-88Sigma81381
MicroscopeOlympusAX-70
CCD cameraSPOTInsight 2MP Firewire
X-ray filmFujifilmSuper RX
Film processing machineFujifilmFPM-100A

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Patiño, C., Haenni, A. L., Urcuqui-Inchima, S. NF90 isoforms, a new family of cellular proteins involved in viral replication? Biochimie. 108, 20-24 (2015).
  2. Shim, J., Lim, H., R Yates, J., Karin, M. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol Cell. 10 (6), 1331-1344 (2002).
  3. Sakamoto, S., et al. The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol Cell Biol. 29 (13), 3754-3769 (2009).
  4. Dresios, J., et al. Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis. Proc Natl Acad Sci. 102 (6), 1865-1870 (2005).
  5. Danno, S., Itoh, K., Matsuda, T., Fujita, J. Decreased expression of mouse Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis. Am J Pathol. 156 (5), 1685-1692 (2000).
  6. Wellmann, S., et al. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J Cell Sci. 117 (Pt 9), 1785-1794 (2004).
  7. Zhu, X., Zelmer, A., Kapfhammer, J. P., Wellmann, S. Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress. FASEB J. 30 (2), 624-634 (2016).
  8. Fields, S., Song, O. A novel genetic system to detect protein-protein interactions. Nature. 340 (6230), 245-246 (1989).
  9. Verhelst, J., De Vlieger, D., Saelens, X. Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein. J Vis Exp. (98), (2015).
  10. Söderberg, O., et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 3 (12), 995-1000 (2007).
  11. Jarvius, M., et al. In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol Cell Proteomics. 6 (9), 1500-1509 (2007).
  12. Liu, C. H., et al. Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma. Mol Cell Proteomics. 12 (5), 1335-1349 (2013).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Nuclear Cytoplasmic FractionsWestern Blot AnalysisImmunocytochemistryHEK293 CellsNF90 RBM3 InteractionCellular Compartment AnalysisFluorescence Microscopy

Related Articles